# Vasorelaxant and Hypotensive Mechanisms of Nelumbo nucifera Seed Extract: Roles of Nitric Oxide, Calcium Channel Blockade and eNOS Interaction with Active Compounds

## TL;DR

This study explores how lotus seed extract helps lower blood pressure by boosting nitric oxide and blocking calcium channels.

## Contribution

The study identifies specific compounds in lotus seed extract that interact with eNOS and contribute to vasorelaxation and antihypertensive effects.

## Key findings

- Lotus seed extract induces vasorelaxation through endothelium-derived NO and calcium channel blockade.
- LSE alkaloids like nelumborine show strong binding affinity to eNOS at the BH4 site.
- LSE reduces blood pressure in a dose-dependent manner in normotensive rats.

## Abstract

Background/Objectives: Enhancing endothelial nitric oxide (NO) bioavailability through natural products may provide a promising strategy for the prevention and management of hypertension. This study investigated the phytochemical composition of ethanolic lotus (Nelumbo nucifera) seed extract (LSE), its vasorelaxant mechanisms, effects on endothelial NO production, and antihypertensive activity. Methods: LSE was characterized via LC-ESI-QTOF-MS using accurate mass data and fragmentation patterns. Vasorelaxant effects were evaluated in isolated rat aortas, and the underlying mechanisms were explored using pharmacological inhibitors. NO production was assessed in human endothelial EA.hy926 cells. Hypotensive activity was examined in normotensive rats following intravenous administration of LSE (10, 30, and 100 mg/kg). Molecular docking was performed to analyze interactions between LSE bioactive compounds and endothelial nitric oxide synthase (eNOS). Results: LC-ESI-QTOF-MS analysis identified 114 compounds, including primary and secondary metabolites. LSE induced vasorelaxation in endothelium-intact aortas, which was reduced by endothelium removal (p < 0.001) and by L-NAME (p < 0.001). LSE also inhibited receptor-operated, Ca2+ channel-mediated vasoconstriction (p < 0.05). In vivo, LSE decreased blood pressure in a dose-dependent manner. In EA.hy926 cells, LSE (750 and 1000 µg/mL) increased NO production, an effect attenuated by L-NAME. Molecular docking showed that LSE alkaloids, including nelumborine, nelumboferine, neferine, and isoliensinine had strong affinities for binding with eNOS at the tetrahydrobiopterin (BH4) binding site. Nelumborine exhibited the highest affinity, suggesting its potential as an eNOS modulator. Conclusions: LSE promotes vasorelaxation through the stimulation of endothelium-derived NO release and Ca2+ influx inhibition, contributing to blood pressure reduction. These findings support LSE as a potential natural antihypertensive supplement.